Track Real Time Price

According to ChemAnalyst , The global Furosemide Prices moved upward during the second quarter of 2026, reflecting a combination of higher producer input costs, changing pharmaceutical demand, feedstock volatility, and regional supply-chain conditions. Furosemide, a widely used loop diuretic, remains an important active pharmaceutical ingredient (API) for the production of medicines used to manage fluid retention associated with conditions such as heart failure, liver disease, and certain kidney disorders. During Q2 2026, price movements varied across major regional markets. In APAC , higher producer costs supported an increase in the Furosemide Price Index, while stable industrial activity helped maintain supply availability. In North America , stronger producer inflation and tighter global chemical supply conditions contributed to higher pricing. Meanwhile, the European market also experienced upward price pressure as energy, naphtha, and intermediate costs increased, particularly i...

Introduction Furosemide, a widely used loop diuretic in the pharmaceutical industry, plays a critical role in treating conditions such as edema, hypertension, and heart failure. As an essential drug, its pricing dynamics are influenced not only by traditional supply-demand fundamentals but also by macroeconomic indicators, production costs, energy prices, and healthcare demand trends. In Q3 2025, the global  Furosemide prices  landscape presented a mixed trajectory across major regions, including North America, Asia-Pacific (APAC), and Europe. While the United States experienced a price increase driven by rising costs and strong demand, China witnessed a decline due to overcapacity and weak consumption. Meanwhile, Europe showed a softer pricing trend despite persistent energy cost pressures. Furosemide Prices in North America Rising Prices in the United States In Q3 2025,  Furosemide prices in the United States  recorded a notable increase, primarily driven by higher...